Antisense-Mediated Exon Skipping for Duchenne Muscular Dystrophy

被引：0
|
作者：
Aartsma-Rus, Annemieke [1 ]
Heemskerk, Hans [1 ]
de Winter, Christa [1 ]
van Putten, Maaike [1 ]
Janson, Anneke [2 ]
Verschuuren, Jan [3 ]
den Dunnen, Johan [1 ]
van Deutekom, Judith [2 ]
van Ommen, Gert-Jan [1 ]
机构：
[1] Leiden Univ, Dept Human Genet, Med Ctr, NL-2300 RA Leiden, Netherlands
[2] Prosensa Therapeut BV, Leiden, Netherlands
[3] Leiden Univ, Med Ctr, Dept Neurol, Leiden, Netherlands
来源：
HUMAN GENE THERAPY | 2009年 / 20卷 / 06期
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
引用
收藏
页码：660 / 661
页数：2
相关论文
共 50 条
  • [1] Optimization of antisense-mediated exon skipping for Duchenne muscular dystrophy
    Dzierlega, Kasia
    Yokota, Toshifumi
    GENE THERAPY, 2020, 27 (09) : 407 - 416
  • [2] Optimization of antisense-mediated exon skipping for Duchenne muscular dystrophy
    Kasia Dzierlega
    Toshifumi Yokota
    Gene Therapy, 2020, 27 : 407 - 416
  • [3] Development of Antisense-Mediated Exon Skipping as a Treatment for Duchenne Muscular Dystrophy
    Heemskerk, Hans
    de Winter, Christa L.
    van Ommen, Gert-Jan B.
    van Deutekom, Judith C. T.
    Aartsma-Rus, Annemieke
    OLIGONUCLEOTIDE THERAPEUTICS, 2009, 1175 : 71 - 79
  • [4] Optimization of therapeutic antisense-mediated exon skipping for Duchenne muscular dystrophy
    Aartsma-Rus, Annemieke
    Heemskerk, Hans
    De Winter, Christa
    Janson, Anneke
    Van Ommen, Gert-Jan
    Van Deutekom, Judith
    HUMAN GENE THERAPY, 2007, 18 (10) : 983 - 984
  • [5] Antisense oligonucleotide design for therapeutic antisense-mediated exon skipping for Duchenne muscular dystrophy
    Aartsma-Rus, A.
    de Winter, C. L.
    Kaman, W. E.
    Janson, A. A. M.
    van Deutekom, J. C. T.
    NEUROMUSCULAR DISORDERS, 2006, 16 (9-10) : 686 - 686
  • [6] Beyond clinical trials for antisense-mediated exon skipping for Duchenne muscular dystrophy
    Aartsma-Rus, Annemieke
    HUMAN GENE THERAPY, 2014, 25 (11) : A13 - A13
  • [7] Antisense-mediated exon skipping as a gene correction therapy for Duchenne muscular dystrophy
    van Deutekom, J
    Aartsma-Rus, A
    Bremmer-Bout, M
    Janson, A
    den Dunnen, J
    van Ommen, GJ
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2002, 199 : S75 - S76
  • [8] Optimization of antisense-mediated exon skipping in mouse models for Duchenne muscular dystrophy
    Aartsma-Rus, A.
    Heemskerk, H. A.
    de Winter, C. L.
    van Putten, M.
    De Kimpe, S.
    van Deutekom, J. C. T.
    van Ommen, G. J. B.
    NEUROMUSCULAR DISORDERS, 2008, 18 (9-10) : 757 - 757
  • [9] Towards clinical studies on antisense-mediated exon skipping in Duchenne Muscular Dystrophy
    van Ommen, Gert-Jan B.
    Heemskerk, Hans
    Aartsma-Rus, Annemieke
    de Winter, Christa
    van Kuik, Petra
    de Kimpe, Sjef
    Platenburg, Gerard
    van Deutekom, Judith C. T.
    NEUROMUSCULAR DISORDERS, 2006, 16 : S95 - S95
  • [10] Theoretic Applicability of Antisense-Mediated Exon Skipping for Duchenne Muscular Dystrophy Mutations
    Aartsma-Rus, Annemieke
    Fokkema, Ivo
    Verschuuren, Jan
    Ginjaar, Leke
    van Deutekom, Judith
    van Ommen, Gert-Jan
    den Dunnen, Johan T.
    HUMAN MUTATION, 2009, 30 (03) : 293 - 299
12345